World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Bioengineered instrument reveals hidden cancer cells

Bioengineered instrument reveals hidden cancer cells

by admin | Sep 19, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Taylor Mixides – Drug Target Review Scientists at Stanford University have engineered a biomolecule that can specifically remove mucins from cancer cells. This breakthrough could have a significant impact on future cancer therapies. Cancer cells can elude the...
From Lift Off to Splash Down: An Update on Mayo Clinic Stem Cells in Space

From Lift Off to Splash Down: An Update on Mayo Clinic Stem Cells in Space

by admin | Sep 18, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Lynda De Widt – Mayo Clinic Growing up in Nigeria, Dr. Zubair had high ambitions, including dreams of becoming an astronaut. Though he has not taken flight, his work has – literally. In 2017, several samples of donated stem cells from Dr. Zubair’s lab...
NASA, Partners Clear Axiom Space’s Third Private Astronaut Crew

NASA, Partners Clear Axiom Space’s Third Private Astronaut Crew

by admin | Sep 16, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By NASA NASA and its international partners approved the crew for Axiom Space’s third private astronaut mission to the International Space Station, launching from the agency’s Kennedy Space Center in Florida no earlier than January 2024. Axiom Space’s chief astronaut...
Ian Wilmut, Scientist Behind Dolly the Cloned Sheep, Is Dead at 79

Ian Wilmut, Scientist Behind Dolly the Cloned Sheep, Is Dead at 79

by admin | Sep 15, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Clay Risen and Amanda Holpuch – The New York Times Ian Wilmut, the British scientist who led the project that cloned a mammal for the first time, Dolly the sheep, shocking scientists who had thought that such a procedure was impossible, died on Sunday. He was...
CRISPR used to ‘reprogram’ cancer cells into healthy muscle in the lab

CRISPR used to ‘reprogram’ cancer cells into healthy muscle in the lab

by admin | Sep 14, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Live Science Scientists have transformed cancer cells into healthy muscle tissue in the lab using CRISPR gene-editing technology — and they hope new cancer treatments can be built on the back of this experiment. In a study published Aug. 28 in the journal PNAS,...
Gene therapy for brain tumor shows promising early results in humans

Gene therapy for brain tumor shows promising early results in humans

by admin | Sep 13, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Ann Megdell – Michigan Medicine A study from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending...
Page 86 of 191« First«...102030...8485868788...100110120...»Last »

Recent Posts

  • Bioinformatics Uncovers Regenerative Therapy for Spinal Cord Injury
  • CAR NK cell therapy clinical trial puts follicular lymphoma survivor into remission
  • Stem cell therapy linked to lower risk of heart failure after a heart attack
  • Embryo-Like ‘Blood Factories’ Could One Day Supplement Donations
  • Long-Term Growth Hormone Therapy Boosts Pediatric Stem Cells
  • New UCLA drug could restore heart and organ function
World Stem Cell Summit Logo - White version
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow